Maybe we get some feedback how well vascepa is doing, pressuring GSK lovaza sales. Website of Lovaza is still mentioning on top: this site is currently unavailable, please check back soon
It'll give us the baseline to measure against next Q. It'll mean nothing this time around.
I meant to say that GSK may mention that Lovaza sales are in decline or maybe looking to add a drug to strengthen in that market segment.